Good Life Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.24M | Buy |
15,663
+4,141
| +36% | +$329K | 0.08% | 182 |
|
|
2025
Q1 | $1.03M | Buy |
11,522
+767
| +7% | +$71.6K | 0.07% | 192 |
|
|
2024
Q4 | $1.07M | Sell |
10,755
-2,218
| -17% | -$229K | 0.08% | 181 |
|
|
2024
Q3 | $1.47M | Buy |
12,973
+3,824
| +42% | +$454K | 0.09% | 172 |
|
|
2024
Q2 | $1.13M | Buy |
9,149
+75
| +0.8% | +$9.66K | 0.09% | 170 |
|
|
2024
Q1 | $1.2M | Sell |
9,074
-4,352
| -32% | -$536K | 0.11% | 147 |
|
|
2023
Q4 | $1.46M | Buy |
13,426
+1,993
| +17% | +$207K | 0.14% | 125 |
|
|
2023
Q3 | $1.18M | Buy |
11,433
+236
| +2% | +$25.4K | 0.13% | 132 |
|
|
2023
Q2 | $1.29M | Sell |
11,197
-1,577
| -12% | -$179K | 0.15% | 126 |
|
|
2023
Q1 | $1.36M | Buy |
12,774
+348
| +3% | +$37.6K | 0.17% | 115 |
|
|
2022
Q4 | $1.38M | Buy |
12,426
+224
| +2% | +$22.9K | 0.19% | 111 |
|
|
2022
Q3 | $1.05M | Buy |
12,202
+1,952
| +19% | +$174K | 0.16% | 118 |
|
|
2022
Q2 | $934K | Buy |
10,250
+187
| +2% | +$16.6K | 0.13% | 127 |
|
|
2022
Q1 | $826K | Sell |
10,063
-595
| -6% | -$46.9K | 0.1% | 144 |
|
|
2021
Q4 | $817K | Buy |
10,658
+2,029
| +24% | +$162K | 0.1% | 150 |
|
|
2021
Q3 | $648K | Sell |
8,629
-2,353
| -21% | -$179K | 0.09% | 162 |
|
|
2021
Q2 | $854K | Buy |
10,982
+6,316
| +135% | +$470K | 0.16% | 106 |
|
|
2021
Q1 | $341K | Buy |
4,666
+714
| +18% | +$52.7K | 0.07% | 207 |
|
|
2020
Q4 | $306K | Buy |
3,952
+40
| +1% | +$3.06K | 0.07% | 189 |
|
|
2020
Q3 | $311K | Buy |
3,912
+4
| +0.1% | +$313 | 0.08% | 171 |
|
|
2020
Q2 | $288K | Sell |
3,908
-1,425
| -27% | -$107K | 0.09% | 171 |
|
|
2020
Q1 | $392K | Buy |
5,333
+1,242
| +30% | +$97.6K | 0.14% | 126 |
|
|
2019
Q4 | $355K | Sell |
4,091
-14
| -0.3% | -$1.15K | 0.1% | 165 |
|
|
2019
Q3 | $327K | Buy |
4,105
+28
| +0.7% | +$2.24K | 0.1% | 162 |
|
|
2019
Q2 | $325K | Sell |
4,077
-767
| -16% | -$58.7K | 0.09% | 160 |
|
|
2019
Q1 | $385K | Buy |
4,844
+513
| +12% | +$38.4K | 0.11% | 141 |
|
|
2018
Q4 | $316K | Buy |
4,331
+575
| +15% | +$40.6K | 0.1% | 155 |
|
|
2018
Q3 | $254K | Buy |
3,756
+101
| +3% | +$6.43K | 0.07% | 202 |
|
|
2018
Q2 | $212K | Sell |
3,655
-591
| -14% | -$33.3K | 0.07% | 212 |
|
|
2018
Q1 | $215K | Sell |
4,246
-668
| -14% | -$36.1K | 0.07% | 194 |
|
|
2017
Q4 | $266K | Sell |
4,914
-494
| -9% | -$27.4K | 0.08% | 180 |
|
|
2017
Q3 | $334K | Sell |
5,408
-753
| -12% | -$45.7K | 0.13% | 132 |
|
|
2017
Q2 | $371K | Buy |
6,161
+434
| +8% | +$26.4K | 0.16% | 113 |
|
|
2017
Q1 | $347K | Buy |
5,727
+2,137
| +60% | +$130K | 0.17% | 113 |
|
|
2016
Q4 | $214K | Buy |
+3,590
| New | +$210K | 0.12% | 140 |
|
Other funds holding MRK
Good Life Advisors's MRK Position: Q2 2025 in Review
Good Life Advisors increased its Merck (MRK) stake by 36% in Q2 2025, buying an estimated $329K and bringing the position to 15,663 shares worth $1.24M. The position accounts for 0.08% of the portfolio, ranked #182.
Good Life Advisors first reported a position in MRK in Q4 2016 and has held it in 35 quarters since. The position peaked at $1.47M in Q3 2024. 3,328 funds tracked by Wall St. Rank hold MRK as of Q2 2025.
- Good Life Advisors held 15,663 shares of Merck worth $1.24M as of Q2 2025.
- Good Life Advisors bought 4,141 Merck shares in Q2 2025, an estimated $329K.
- Merck made up 0.08% of Good Life Advisors's portfolio in Q2 2025, its #182 holding.
- Good Life Advisors first reported a position in Merck in Q4 2016 and has held it in 35 quarters since.
- Good Life Advisors's Merck position peaked at $1.47M in Q3 2024.
- 3,328 funds tracked by Wall St. Rank held Merck as of Q2 2025.
Based on Good Life Advisors's 13F filing for Q2 2025, filed 8 Aug 2025.